Bimi International Medical Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $1.99 million
- Book Value:
- Revenue TTM:
- $19.14 million
- Operating Margin TTM:
- Gross Profit TTM:
- $4.60 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Bimi International Medical Inc had its IPO on 2006-10-18 under the ticker symbol BIMI.
The company operates in the Healthcare sector and Pharmaceutical Retailers industry. Bimi International Medical Inc has a staff strength of 524 employees.
Shares of Bimi International Medical Inc opened at $0.52 at the start of the last trading session i.e. 2023-03-31.
The stocks traded within a range of $0.52 - $0.55, and closed at $0.55.
This is a +5.54% increase from the previous day's closing price.
A total volume of 26,790 shares were traded at the close of the day’s session.
In the last one week, shares of Bimi International Medical Inc have slipped by -10.03%.
Bimi International Medical Inc's Key Ratios
Bimi International Medical Inc has a market cap of $1.99 million, indicating a price to book ratio of 1.1101 and a price to sales ratio of 0.5061.
In the last 12-months Bimi International Medical Inc’s revenue was $19.14 million with a gross profit of $4.60 million and an EBITDA of $-10871728. The EBITDA ratio measures Bimi International Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Bimi International Medical Inc’s operating margin was -57.99% while its return on assets stood at -14.44% with a return of equity of -178.88%.
In Q3, Bimi International Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 46.9%.
Bimi International Medical Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-69.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bimi International Medical Inc’s profitability.
Bimi International Medical Inc stock is trading at a EV to sales ratio of 1.1728 and a EV to EBITDA ratio of -0.5674. Its price to sales ratio in the trailing 12-months stood at 0.5061.
Bimi International Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $33.00 million
- Total Liabilities
- $18.90 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Bimi International Medical Inc ended 2023 with $33.00 million in total assets and $0 in total liabilities. Its intangible assets were valued at $33.00 million while shareholder equity stood at $9.80 million.
Bimi International Medical Inc ended 2023 with $0 in deferred long-term liabilities, $18.90 million in other current liabilities, 38435.00 in common stock, $-58498042.00 in retained earnings and $8.38 million in goodwill. Its cash balance stood at $1.05 million and cash and short-term investments were $1.05 million. The company’s total short-term debt was $8,722,779 while long-term debt stood at $475049.00.
Bimi International Medical Inc’s total current assets stands at $17.38 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $9.44 million compared to accounts payable of $4.23 million and inventory worth $1.23 million.
In 2023, Bimi International Medical Inc's operating cash flow was $-180000.00 while its capital expenditure stood at $0.
Comparatively, Bimi International Medical Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Bimi International Medical Inc stock is currently trading at $0.55 per share. It touched a 52-week high of $15.7 and a 52-week low of $15.7. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $1.14 and 200-day moving average was $3.03 The short ratio stood at 6.01 indicating a short percent outstanding of 0%.
Around 3669.9% of the company’s stock are held by insiders while 36.4% are held by institutions.
Frequently Asked Questions About Bimi International Medical Inc
Similar Industry Stocks (Pharmaceutical Retailers)
BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People’s Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People’s Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People’s Republic of China.